Oncology Precision medicine Digital and computational pathology Omics Molecular Pathology Research and Innovations

Multiomics Improves Late-stage Melanoma Survival

How a single-cell proteomics test, run on a standard pathology slide, can reshape treatment decisions

By Helen Bristow 09/09/2025 Technology 4 min read

article Full Article subjectSummary summarizeNotecard

Share

0

Multiomics approach increases progression-free survival in melanoma patients.
Spatial proteomics helps tailor therapy decisions.
Study led by experts including Stéphane Chevrier.
Testing costs reduced to less than 14,000 Swiss francs.
Critical need for access to off-label drugs to improve treatment efficacy.

About the Author(s)

Helen Bristow

Combining my dual backgrounds in science and communications to bring you compelling content in your speciality.

More Articles by Helen Bristow